Tonix Pharmaceuticals promotes Thomas Englese to Chief Commercial Officer

Tonix Pharmaceuticals Holding Corp.

Thomas Englese appointed Chief Commercial Officer, effective Sept 8, 2026, after serving as EVP Commercial Operations since 2024.
Englese oversees commercial organization for TONMYA (fibromyalgia) and migraine products Zembrace SymTouch and Tosymra.
Previous roles include CCO at Tris Pharma and Aziyo, and SVP/GM at Mallinckrodt.
CEO Seth Lederman cites Englese's role in TONMYA launch; focus on expanding access and sales.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.